<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0606222138
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2000
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Juvamox 500MG CAPSULES
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        22.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CA04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Juvamox is Juvamox </strong>contains amoxicillin as the active ingredient which belongs to a class of antibiotics called &lsquo;penicillins&rsquo;. <strong>Juvamox</strong> is used to treat infections caused by bacteria in different parts of the body. <strong>Juvamox</strong> may also be used in combination with other medicines to treat stomach ulcers.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p><strong>Do not take Juvamox:</strong></p><p>&middot;&nbsp;&nbsp; if you are allergic to amoxicillin, penicillin or any of the other ingredients of this medicine (listed in section 6).</p><p>&middot;&nbsp;&nbsp; if you have ever had an allergic reaction to any antibiotic. This can include a skin rash or swelling of the face or throat.</p><p>Do not take <strong>Juvamox</strong> if any of the above apply. If you are not sure, talk to your doctor or pharmacist before taking <strong>Juvamox</strong>.</p><p><strong>Warnings and Precautions </strong></p><p>Talk to your doctor or pharmacist before taking <strong>Juvamox</strong> if you:</p><p>&middot;&nbsp;&nbsp; have kidney problems</p><p>&middot;&nbsp;&nbsp; have glandular fever (fever, sore throat, swollen glands and extreme tiredness)</p><p>&middot;&nbsp;&nbsp; are not urinating regularly.</p><p>If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking <strong>Juvamox</strong>.</p><p><strong>Having urine or blood tests </strong></p><p>If you are having:</p><p>&middot;&nbsp;&nbsp; Urine tests (glucose) or blood tests for liver function</p><p>&middot;&nbsp;&nbsp; Oestriol tests (used during pregnancy to check the baby is developing normally)</p><p>Tell your doctor or pharmacist that you are taking <strong>Juvamox</strong>. This is because <strong>Juvamox</strong> can affect the results of these tests.</p><p><strong>Other medicines and Juvamox</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>&middot;&nbsp;&nbsp; If you are taking allopurinol (used for gout) with Juvamox, it may be more likely that you will have an allergic skin reaction.</p><p>&middot;&nbsp;&nbsp; If you are taking probenecid (used for gout), your doctor may decide to adjust the dose of Juvamox.</p><p>&middot;&nbsp;&nbsp; If you are taking medicines to help stop blood clots (such as warfarin), you may need extra blood tests.</p><p>&middot;&nbsp;&nbsp; If you are taking other antibiotics (such as tetracycline) Juvamox may be less effective.</p><p>&middot;&nbsp;&nbsp; If you are taking methotrexate (used for the treatment of cancer and severe psoriasis) Juvamox may cause an increase in side effects.</p><p><strong>Juvamox with food and drink </strong></p><p>These capsules may be taken before, during orafteryour meals.</p><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. <strong>Juvamox</strong> passes into breast milk, so tell your doctor if you are breast-feeding. Ask your doctor for advice before taking any medicine.</p><p><strong>Driving and using machines </strong></p><p><strong>Juvamox </strong>can have side effects and the symptoms (such as allergic reactions, dizziness and convulsions) may make you unfit to drive.</p><p>Do not drive or operate machinery unless you are feeling well.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&middot;&nbsp;&nbsp; Swallow with water without opening capsule.</p><p>&middot;&nbsp;&nbsp; Space the doses evenly during the day, at least 4 hours apart.</p><p><strong>The recommended dose is: </strong></p><p><strong><u>Children weighing less than 40 kg </u></strong></p><p>All doses are worked out depending on the child&rsquo;s body weight in kilograms.</p><p>&middot;&nbsp;&nbsp; Your doctor will advise you how much <strong>Juvamox</strong> you should give to your baby or child.</p><p>&middot;&nbsp;&nbsp; The usual dose is 40 mg to 90 mg for each kilogram of body weight a day, given in two or three divided doses.</p><p>&middot;&nbsp;&nbsp; The maximum recommended dose is 100 mg for each kilogram of body weight a day.</p><p><strong><u>Adults, elderly patients and children weighing 40 kg or more</u></strong></p><p>The usual dose of <strong>Juvamox</strong> is 250 mg to 500 mg three times a day or 750 mg to 1 g every 12 hours, depending on the severity and type of infection.</p><p>&middot;&nbsp;&nbsp; <strong>Severe infections: </strong>750 mg to 1 g three times a day.</p><p>&middot;&nbsp;&nbsp; <strong>Urinary tract infection: </strong>3 g twice daily for one day.</p><p>&middot;&nbsp;&nbsp; <strong>Lyme disease (an infection spread by parasites called ticks): </strong>Isolated erythema migrans (early stage &ndash; red or pink circular rash): &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4 g a day, Systemic manifestations (late stage &ndash; for more serious symptoms or when the disease spreads around your body): up to 6 g a day.</p><p>&middot;&nbsp;&nbsp; <strong>Stomach ulcers:</strong> one 750 mg or one 1 g dose twice a day for 7 days with other antibiotics and medicines to treat stomach ulcers.</p><p>&middot;&nbsp;&nbsp; <strong>To prevent heart infection during surgery: </strong>the dose will vary according to the type of surgery. Other medicines may also be given at the same time. Your doctor, pharmacist or nurse can give you more details.</p><p>&middot;&nbsp;&nbsp; The maximum recommended dose is 6 g per day.</p><p><strong>Kidney problems</strong></p><p>If you have kidney problems the dose might be lower than the usual dose.</p><p><strong>If you take more Juvamox than you should </strong></p><p>If you have taken too much <strong>Juvamox</strong>, signs might be an upset stomach (feeling sick, being sick or diarrhoea) or crystals in the urine, which may be seen as cloudy urine, or problems urinating. Talk to your doctor as soon as possible. Take the medicine to show the doctor.</p><p><strong>If you forget to take Juvamox&nbsp; </strong></p><p>&middot;&nbsp;&nbsp; If you forget to take a dose, take it as soon as you remember.</p><p>&middot;&nbsp;&nbsp; Do not take the next dose too soon, wait about 4 hours before taking the next dose.</p><p>&middot;&nbsp;&nbsp; Do not take a double dose to make up for a forgotten dose.</p><p><strong>How long should you take Juvamox for? </strong></p><p>&middot;&nbsp;&nbsp; Keep taking <strong>Juvamox</strong> for as long as your doctor has told you to, even if you feel better. You need every dose to help fight the infection. If some bacteria survive they can cause the infection to come back.</p><p>&middot;&nbsp;&nbsp; Once you finish treatment, if you still feel unwell you should go back to see the doctor.</p><p>Thrush (a yeast infection of moist areas of the body which can cause soreness, itching and white discharge) may develop if <strong>Juvamox</strong> is used for a long time. If this occurs tell your doctor.</p><p>If you take <strong>Juvamox</strong> for a long time, your doctor may perform additional tests to check your kidneys, liver and blood are working normally.</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everyone gets them.</p><p><strong>Stop taking Juvamox and see a doctor straight away, if you notice any of the following serious side effects &ndash; you may need urgent medical treatment:&nbsp; </strong></p><p>The following are very rare (may affect up to 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp; allergic reactions, the signs may include: skin itching or rash, swelling of the face, lips, tongue, body or breathing difficulties. These can be serious and occasionally deaths have occurred</p><p>&middot;&nbsp;&nbsp; rash or pinpoint flat red round spots under the skin surface or bruising of the skin. This is due to an inflammation of blood vessel walls due to an allergic reaction. It can be associated with joint pain (arthritis) and kidney&nbsp; problems</p><p>&middot;&nbsp;&nbsp; a delayed allergic reaction can occur usually 7 to 12 days after having amoxicillin, some signs include: rashes, fever, joint pains and enlargement of lymph nodes especially under the arms</p><p>&middot;&nbsp;&nbsp; a skin reaction known as &lsquo;erythema multiforme&rsquo; where you may develop: itchy reddish purple patches on the skin especially on the palms of the hands or soles of the feet, &lsquo;hive-like&rsquo; raised swollen areas on the skin,&nbsp; tender areas on the surfaces of the mouth, eyes and genitals. You may have a fever and be very tired</p><p>&middot;&nbsp;&nbsp; other severe skin reactions can include: changes in skin colour, bumps under the skin, blistering, pustules, peeling, redness, pain, itching, scaling. These may be associated with fever, headaches and body aches&nbsp;</p><p>&middot;&nbsp;&nbsp; fever, chills, a sore throat or other signs of an infection, or if you bruise easily. These may be signs of a problem with your blood cells.</p><p>&middot;&nbsp;&nbsp; flu-like symptoms with a rash, fever, swollen glands, and abnormal blood test results (including increased white blood cells (eosinophilia) and liver enzymes) (Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)).</p><p>&middot;&nbsp;&nbsp; the Jarisch-Herxheimer reaction which occurs during treatment with amoxicillin for Lyme disease and causes fever, chills, headache, muscle pain and skin rash.</p><p>&middot;&nbsp;&nbsp; inflammation of the large bowel (colon) with diarrhoea (sometimes containing blood), pain and fever</p><p>&middot;&nbsp;&nbsp; serious liver side effects may occur. They are mainly associated with people having treatment over a long period, males and the elderly. You must tell your doctor urgently if you get:</p><p>-&nbsp; severe<strong> </strong>diarrhoea with bleeding</p><p>-&nbsp; blisters, redness or bruising of the skin</p><p>-&nbsp; darker urine or paler stools</p><p>-&nbsp; yellowing of the skin or the whites of the eyes (jaundice). See also anaemia below which might result in jaundice.</p><p>These can happen when having the medicine or for up to several weeks after.</p><p><strong>If any of the above happens stop taking the medicine and see your doctor straight away. </strong></p><p><strong>Sometimes you may get less severe skin reactions such as: </strong></p><p>&middot;&nbsp;&nbsp; a mildly itchy rash (round, pink-red patches), &lsquo;hive-like&rsquo; swollen areas on forearms, legs, palms, hands or feet. This is uncommon (may affect up to 1 in 100 people).</p><p><strong>If you have any of these talk to your doctor as amoxicillin</strong> <strong>will need to be stopped. </strong></p><p><strong>The other possible side effects are: </strong></p><p><strong>Common </strong>(may affect up to 1 in 10 people)<strong> </strong></p><p>&middot;&nbsp;&nbsp; skin rash</p><p>&middot;&nbsp;&nbsp; feeling sick (nausea)</p><p>&middot;&nbsp;&nbsp; diarrhoea.</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&middot;&nbsp;&nbsp; being sick (vomiting).</p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people)</p><p>&middot;&nbsp;&nbsp; thrush (a yeast infection of the vagina, mouth or skin folds), you can get treatment for thrush from your doctor or pharmacist</p><p>&middot;&nbsp;&nbsp; kidney problems</p><p>&middot;&nbsp;&nbsp; fits (convulsions), seen in patients on high doses or with kidney problems</p><p>&middot;&nbsp;&nbsp; dizziness</p><p>&middot;&nbsp;&nbsp; hyperactivity</p><p>&middot;&nbsp;&nbsp; crystals in the urine, which may be seen as cloudy urine, or difficulty or discomfort in passing urine. Make sure you drink plenty of fluids to reduce the chance of these symptoms</p><p>&middot;&nbsp;&nbsp; the tongue may change to yellow, brown or black and it may have a hairy appearance</p><p>&middot;&nbsp;&nbsp; an excessive breakdown of red blood cells causing a type of anaemia.&nbsp; Signs include: tiredness, headaches, shortness of breath, dizziness, looking pale and yellowing of the skin and the whites of the eyes</p><p>&middot;&nbsp;&nbsp; low number of white blood cells</p><p>&middot;&nbsp;&nbsp; low number of cells involved with blood clotting</p><p>&middot;&nbsp;&nbsp; the blood may take longer to clot than it normally would. You may notice this if you have a nosebleed or cut yourself.</p><p>&middot;&nbsp;&nbsp; inflammation of the protective membrane surrounding the brain (aseptic meningitis).</p><p><strong><u>Reporting of side effects</u></strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p><strong>Saudi Arabia:</strong></p><p><strong>The National Pharmacovigilance Centre (NPC):</strong></p><p><strong>-&nbsp; SFDA Call Centre: </strong>19999</p><p><strong>-&nbsp; E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>-&nbsp; Website:</strong> https://ade.sfda.gov.sa/</p><p><strong>Other GCC States:</strong></p><p>-&nbsp; Please contact the relevant competent authority.</p><p>By reporting side effects, you can help provide more information on the safety of this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not take this medicine after the expiry date which is stated on the carton and on the blister.</p><p>-&nbsp; The expiry date refers to the last day of that month.</p><p>-&nbsp; Store below 30&deg;C, in a dry place, protected from light.</p><p>-&nbsp; Do not take this medicine if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should not be disposed off via wastewater or household waste. Ask your pharmacist how to dispose off medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is amoxicillin. Each capsule contains amoxicillin trihydrate equivalent to amoxicillin 500mg.</p><p>Other ingredients: Magnesium stearate and gelatin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Juvamox 500mg capsules is available in packs of 12, 20 or 100 capsules and hospital packs of 1000 capsules.       


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
15/07/2022


            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>ما هو جوڤاموكس </strong></p><p dir="RTL">يحتوي <strong>جوڤاموكس</strong> على المادة الفعالة أموكسيسيلين التي تنتمي إلى مجموعة الأدوية التي تعرف باسم &rsquo;البنسيلينات‛. يُستعمل <strong>جوڤاموكس</strong> لعلاج العدوى التي تسببها البكتيريا في مختلف أنحاء الجسم.</p><p dir="RTL">كما يمكن استعمال <strong>جوڤاموكس</strong> بالاشتراك مع أدوية أخرى لعلاج قرحة المعدة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم تناول جوڤاموكس في الحالات التالية:</strong></p><p dir="RTL">&middot; إذا كنت تعاني من الحساسية تجاه أموكسيسيلين، بنسيلين أو تجاه أياً من المكونات الأخرى في هذا الدواء (المدرجة في البند رقم 6).</p><p dir="RTL"><strong>&middot; </strong>إذا عانيت مسبقاً من أية تفاعلات تحسسية تجاه أياً من المضادات الحيوية، بما في ذلك الطفح الجلدي أو تورم الوجه أو الحلق.</p><p dir="RTL">يجب عليك عدم تناول <strong>جوڤاموكس</strong> إذا كان أياً مما ذكر أعلاه ينطبق عليك. يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>جوڤاموكس</strong>، إذا كان لديك أدنى شك بذلك.</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول<strong> جوڤاموكس </strong>في الحالات التالية:</p><p dir="RTL">&middot; إذا كنت تعاني من اضطرابات في الكلى</p><p dir="RTL">&middot; إذا كنت تعاني من حمى غدية (حمى، احتقان الحلق، تورم الغدد، تعب شديد)</p><p dir="RTL">&middot; إذا كنت تعاني من اضطراب في التبول.</p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>جوڤاموكس، </strong>إذا كان لديك شك بأن أياً مما ذكر أعلاه ينطبق عليك.</p><p dir="RTL"><strong>فحوصات البول أو الدم</strong></p><p dir="RTL">إذا كنت على وشك إجراء الفحوصات التالية:</p><p dir="RTL">&middot; فحوصات البول (للكشف عن الجلوكوز) أو فحوصات الدم لوظائف الكبد.</p><p dir="RTL">&middot; فحوصات إستريول (يُجرى أثناء فترة الحمل للتأكد من طور نمو الجنين بصورة طبيعية).</p><p dir="RTL">فيرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه أنك تتناول <strong>جوڤاموكس</strong>، وذلك لأن <strong>جوڤاموكس</strong> قد يؤثر على نتائج هذه الفحوصات.</p><p dir="RTL"><strong>تناول الأدوية الأخرى بالتزامن مع جوڤاموكس </strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول، تناولت مؤخراً أو قد تتناول أية أدوية أخرى.</p><p dir="RTL">&middot;&nbsp; إذا كنت تتناول ألوبيورينول (دواء يستخدم لعلاج داء النقرس) بالتزامن مع <strong>جوڤاموكس</strong>، فإنه من المرجح أن تتعرض لتفاعل جلدي تحسسي.</p><p dir="RTL">&middot;&nbsp; إذا كنت تتناول بروبنيسيد (دواء يستخدم لعلاج داء النقرس)، فقد يقوم طبيبك المعالج بتعديل مقدار&nbsp;&nbsp; جرعة <strong>جوڤاموكس </strong>الخاصة بك.</p><p dir="RTL">&middot;&nbsp; إذا كنت تتناول أدوية لمنع تجلط الدم (على سبيل المثال الوارفارين)، فقد تكون بحاجة إلى إجراء فحوصات دم إضافية.</p><p dir="RTL">&middot;&nbsp; إذا كنت تتناول مضادات حيوية أخرى (على سبيل المثال تتراسيكلين)، فقد يكون <strong>جوڤاموكس</strong> أقل فعالية.</p><p dir="RTL">&middot;&nbsp; إذا كنت تتناول ميثوتركسيت (يستخدم لعلاج السرطان والصدفية الشديدة)، فقد يؤدي <strong>جوڤاموكس</strong> إلى زيادة حدوث التأثيرات الجانبية.</p><p dir="RTL"><strong>تناول جوڤاموكس بالتزامن مع الطعام والشراب</strong><br />من الممكن تناول هذه الكبسولات قبل، أثناء أو بعد وجبات الطعام.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعاملين معه للحصول على النصيحة قبل تناول هذا الدواء إذا كنت حاملاً أو ترضعين طفلك رضاعة طبيعية، تعتقدين أنك حامل، أو تخططين لذلك. يرجى منك إخبار طبيبك المعالج إذا كنت ترضعين طفلك رضاعة طبيعية حيث أنه قد يطرح <strong>جوڤاموكس </strong>في حليب الثدي، يجب عليك التحدث إلى طبيبك المعالج للحصول على النصيحة قبل تناول أية أدوية.&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات </strong></p><p dir="RTL">قد يؤدي <strong>جوڤاموكس </strong>إلى حدوث تأثيرات جانبية وظهور الأعراض (على سبيل المثال تفاعلات تحسسية، دوخة واختلاجات) التي قد تجعلك غير مؤهل للقيادة. يجب عليك عدم القيادة أو تشغيل الآلات إلى أن تشعر بالتحسن.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائماً تناول هذا الدواء بدقة تبعاً لتعليمات طبيبك المعالج أو الصيدلي الذي تتعامل معه. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا لم تكن متأكداً من كيفية تناول هذا الدواء.</p><p dir="RTL">&middot; يرجى منك ابتلاع الكبسولة مع الماء دون إفراغ محتواها.</p><p dir="RTL">&middot; يرجى منك ترك فترة زمنية متساوية بين كل جرعة وأخرى خلال اليوم، بحيث لا تقل عن 4 ساعات.</p><p dir="RTL"><strong>يبلغ مقدار الجرعة الموصى بها:</strong></p><p dir="RTL"><strong><u>الأطفال الذين يزنون أقل من 40 كيلوغرام</u></strong><strong> </strong></p><p dir="RTL">يتم تحديد مقدار جميع الجرعات اعتماداً على وزن جسم الطفل بالكيلوغرام.</p><p dir="RTL">&middot; سوف يقدم لك طبيبك المعالج النصيحة حول مقدار الجرعة من <strong>جوڤاموكس</strong> الواجب عليك إعطائها&nbsp; &nbsp;لطفلك.</p><p dir="RTL">&middot; يتراوح مقدار الجرعة الاعتيادية من 40 ملغم إلى 90 ملغم لكل كيلوغرام من وزن الجسم ويتم إعطائها على 2 أو 3 جرعات مقسمة.</p><p dir="RTL">&middot; يبلغ مقدار الجرعة القصوى اليومية 100 ملغم لكل كيلوغرام من وزن الجسم.</p><p dir="RTL"><strong><u>البالغون، فئة كبار السن والأطفال الذين يزنون 40 كيلوغرام أو فما فوق</u></strong><strong> </strong></p><p dir="RTL">يتراوح مقدار الجرعة الاعتيادية من 250 ملغم إلى 500 ملغم 3 مرات في اليوم أو من 750 ملغم إلى 1 غرام كل 12 ساعة، اعتماداً على شدة ونوع العدوى.</p><p dir="RTL"><strong>&middot; </strong><strong>العدوى الشديدة: </strong>يتراوح مقدار الجرعة من 750 ملغم إلى 1 غرام 3 مرات في اليوم.</p><p dir="RTL"><strong>&middot; </strong><strong>عدوى المسالك البولية: </strong>3 غرام مرتين لمدة يوم واحد.</p><p dir="RTL">&middot; <strong>داء لايم (عدوى تنتشر عن طريق الطفيليات تسمى القرادة):</strong> للحالات المعزولة من حُمامى مُهاجِرَة (مرحلة مبكرة &ndash; تظهر على شكل طفح جلدي دائري أحمر أو وردي اللون): يبلغ مقدار الجرعة 4 غرام في اليوم، لحالات التظاهر الجهازي ( مرحلة متأخرة &ndash; ظهور أعراض خطيرة أو عندما ينتشر الداء حول أجزاء الجسم): يصل مقدار الجرعة إلى 6 غرام في اليوم.</p><p dir="RTL"><strong>&middot; </strong><strong>قرحة المعدة: </strong>يبلغ مقدار الجرعة 750 ملغم أو 1 غرام على هيئة جرعة مفردة مرتين في اليوم لمدة 7 أيام بالتزامن مع مضادات حيوية أخرى والأدوية التي تستعمل لعلاج قرحة المعدة.</p><p dir="RTL"><strong>&middot; </strong><strong>لمنع حدوث عدوى القلب أثناء إجراء العمليات الجراحية: </strong>سيختلف مقدار الجرعة باختلاف نوع العملية الجراحية، وكما قد يتم إعطائك أدوية أخرى في نفس الوقت. سوف يقدم طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض تفاصيلاً أكثر حول ذلك.</p><p dir="RTL">&middot; يبلغ مقدار الجرعة القصوى الموصى بها 6 غرام في اليوم.</p><p dir="RTL"><strong>اضطرابات الكلى</strong></p><p dir="RTL">إذا كنت تعاني من اضطرابات في الكلى، فقد تكون بحاجة إلى جرعة بمقدار أقل من مقدار الجرعة الاعتيادية.</p><p dir="RTL"><strong>إذا تناولت جوڤاموكس بجرعة أكبر مما يجب</strong></p><p dir="RTL">إذا تناولت <strong>جوڤاموكس</strong> بجرعة أكبر مما يجب، فقد تتضمن الأعراض على اضطراب في المعدة (الشعور بالإعياء، توعك أو إسهال) أو ظهور بلورات في البول والتي قد تظهر على هيئة بول متعكراً أو مشاكل في التبول. يرجى منك التحدث إلى طبيبك المعالج في أقرب وقت ممكن، مع أخذ هذا الدواء معك لإظهاره له.</p><p dir="RTL"><strong>إذا سهوت عن تناول جوڤاموكس</strong></p><p dir="RTL">&middot; إذا سهوت عن تناول إحدى الجرعات، فيجب عليك تناولها في أسرع وقت ممكن حال تذكرها.</p><p dir="RTL">&middot; يجب عليك عدم تناول الجرعة التالية في الحال، فيجب عليك الانتظار لمدة 4 ساعات قبل تناول الجرعة التالية.</p><p dir="RTL">&middot; يجب عليك عدم تناول جرعة مضاعفة لتعويض الجرعة التي قد سهوت عنها.</p><p dir="RTL"><strong>المدة اللازمة لتناول جوڤاموكس</strong></p><p dir="RTL"><strong>&middot;&nbsp; </strong>يجب الاستمرار<strong> </strong>في تناول <strong>جوڤاموكس </strong>إلى أن تنتهي الدورة العلاجية الموصى بها من قبل طبيبك المعالج حتى وإن كنت تشعر بالتحسن. حيث أنك بحاجة إلى كل جرعة من الجرعات الموصوفة لك للقضاء على العدوى. إذا لم يتم القضاء على جميع البكتيريا المسببة للعدوى فقد تعاود العدوى مرة أخرى.</p><p dir="RTL"><strong>&middot;&nbsp; </strong>يرجى منك مراجعة طبيبك المعالج، في حال مازلت تشعر بعدم التحسن بالرغم من استكمال من الدورة العلاجية.</p><p dir="RTL">قد يؤدي تناول <strong>جوڤاموكس </strong>لفترة زمنية طويلة<strong> </strong>إلى حدوث داء القلاع (هو عدوى ناجمة عن الخمائر التي تصيب مناطق الجسم الرطبة، التي تسبب الألم، حكة وإفرازات بيضاء). يرجى منك إخبار طبيبك المعالج في حال حدوث ذلك.</p><p dir="RTL">إذا كنت تتناول <strong>جوڤاموكس</strong> لفترة زمنية طويلة، فقد يرغب طبيبك المعالج بإجراء فحوصات إضافية للتأكد من كفاءة عمل الكلى، الكبد والدم.</p><p dir="RTL"><strong>يرجى منك استشارة طبيبك أو الصيدلي الذي تتعامل معه، إذا كان لديك أسئلة إضافية حول استعمال هذا الدواء.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن جميع الأدوية، قد يؤدي هذا الدواء إلى حدوث تأثيرات جانبية، على الرغم من ذلك فإنها لا تحدث لكل شخص.</p><p dir="RTL"><strong>يرجى منك التوقف عن تناول جوڤاموكس ورؤية طبيبك المعالج على الفور، في حال ملاحظة أياً من التأثيرات الجانبية الخطيرة التالية- فقد تحتاج إلى تدخل طبي طارئ:</strong></p><p dir="RTL">&middot;&nbsp; التأثيرات الجانبية التالية قد تحدث بصورة نادرة جداً (قد تؤثر ما يصل إلى شخص واحد من كل 10000 شخص)</p><p dir="RTL">&middot;&nbsp; تفاعلات تحسسية، تتضمن علامات حدوث ذلك على: طفح جلدي أو حكة جلدية، تورم الوجه، الشفتين، اللسان، الجسم أو صعوبة في التنفس. قد تكون هذه العلامات خطيرة وفي بعض الأحيان تؤدي إلى الوفاة.</p><p dir="RTL">&middot;&nbsp; طفح جلدي أو بقع حمراء دائرية محددة ومسطحة تحت سطح الجلد أو ظهور كدمات على الجلد، الناجم عن التهاب جدران الأوعية الدموية الناتج عن التفاعلات التحسسية. وقد يصاحب ذلك ألم في المفاصل (التهاب المفاصل) واضطرابات في الكلى.</p><p dir="RTL">&middot;&nbsp; قد يحدث تفاعل تحسسي بصورة متأخرة، عادةً بعد مرور 7 أيام إلى 12 يوم من تناول أموكسيسيلين، وقد تتضمن بعض علامات حدوث ذلك على: طفح جلدي، حمى، آلام في المفاصل، وتضخم الغدد الليمفاوية وبصفة خاصة أسفل الذراعين</p><p dir="RTL">&middot;&nbsp; تفاعل جلدي يعرف باسم &rsquo;حمامى متعددة الأشكال‛ الذي يتمثل في ظهور بقع أرجوانية حمراء على الجلد مصحوبة بحكة وبصفة خاصة على راحتي اليدين أو باطن القدمين، بروز مناطق متورمة على الجلد شبيهة بخلايا النحل، الشعور بالألم عند لمس منطقة سطح الفم، العينين والأعضاء التناسلية. كما قد يحدث حمى والشعور بالتعب الشديد.</p><p dir="RTL">&middot;&nbsp; تتضمن التفاعلات الجلدية الشديدة الأخرى على: تغير لون الجلد، وجود نتوءات تحت الجلد، تقرحات، بثور، تقشر الجلد، احمرار، ألم، حكة. ويُمكن أن يصاحب ذلك حمى، صداع وأوجاع في الجسم.</p><p dir="RTL">&middot;&nbsp; حمى، قشعريرة، احتقان الحلق أو أية علامات أخرى تدل على حدوث العدوى أو الإصابة بالكدمات بسهولة. وقد تكون هذه العلامات نتيجة لوجود مشاكل في خلايا الدم.</p><p dir="RTL">&middot;&nbsp; أعراض شبيهة بأعراض الإنفلونزا مصحوباً بحدوث طفح جلدي، حمى، تورم الغدد ونتائج غير طبيعية لفحوصات الدم (بما في ذلك ارتفاع تعداد خلايا الدم البيضاء (كثرة الحمضات) وإنزيمات الكبد) (التفاعلات الدوائية مصحوباً بحدوث كثرة الحمضات والأعراض الجهازية)</p><p dir="RTL">&middot;&nbsp; تفاعل جاريش- هركسايمر الذي يحدث أثناء فترة العلاج باستخدام أموكسيسيلين لداء لايم والذي يسبب في حدوث حمى، قشعريرة، صداع، ألم في العضلات وطفح جلدي.&nbsp;</p><p dir="RTL">&middot;&nbsp; التهاب الأمعاء الغليظة (القولون) مصحوباً&nbsp; بإسهال (في بعض الأحيان يكون الإسهال مصحوباً بظهور دم)، وألم وحمى</p><p dir="RTL">&middot;&nbsp; تأثيرات جانبية خطيرة على الكبد. يرتبط حدوثها بصورة أساسية في المرضى الذين يتلقون العلاج لفترة طويلة، وكذلك لدى المرضى الذكور، والمرضى المسنين. يجب عليك أن تخبر طبيبك المعالج على الفور إذا عانيت من إحدى الحالات التالية:</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; &ndash;&nbsp;&nbsp; إسهال شديد مصحوب بدم</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; &ndash;&nbsp;&nbsp; تقرحات، إحمرار أو كدمات على الجلد</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; &ndash;&nbsp;&nbsp; بول داكن اللون أو براز باهت اللون</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp; &ndash;&nbsp;&nbsp; إصفرار الجلد أو بياض العينين (يرقان). انظر أيضاً أدناه فيما يتعلق بفقر الدم الذي قد يؤدي إلى حدوث يرقان.</p><p dir="RTL">قد تحدث هذه التأثيرات أثناء تناول الدواء أو بعد تناوله بعدة أسابيع.</p><p dir="RTL"><strong>يرجى منك التوقف عن تناول الدواء والتوجه إلى طبيبك المعالج على الفور، في حال حدوث أياً مما ذكر أعلاه.</strong></p><p dir="RTL"><strong>في بعض الأحيان قد تحدث تفاعلات جلدية أقل حدة، على سبيل المثال:</strong></p><p dir="RTL">&middot;&nbsp; طفح جلدي طفيف مصحوب بحكة (بقع حمراء- وردية اللون ودائرية)، مناطق متورمة من الجلد &nbsp;&rsquo;شبيهة بخلايا النحل‛ على الساعدين، الساقين، راحة اليدين، اليدين أو القدمين. وهذه التأثيرات غير شائعة (تؤثر على ما يصل إلى شخص واحد من كل 100 شخص).</p><p dir="RTL"><strong>يرجى منك التحدث إلى&nbsp; طبيبك المعالج، في حال حدوث أياً من هذه التأثيرات حيث سيتطلب الأمر إيقاف تناول أموكسيسيلين.</strong></p><p dir="RTL"><strong>تتضمن التأثيرات الجانبية الأخرى على:</strong></p><p dir="RTL"><strong>شائعة </strong>(تؤثر على ما يصل إلى شخص واحد من كل 10 أشخاص)</p><p dir="RTL">&middot;&nbsp; طفح جلدي</p><p dir="RTL">&middot;&nbsp; الشعور بإعياء (غثيان)</p><p dir="RTL">&middot;&nbsp; إسهال.</p><p dir="RTL"><strong>غير شائعة </strong>(تؤثر على ما يصل إلى شخص واحد من كل 100 شخص)</p><p dir="RTL">&middot;&nbsp; إعياء (تقيؤ).</p><p dir="RTL"><strong>نادرة جداً</strong> (تؤثر على ما يصل إلى شخص واحد من كل 10000 شخص)</p><p dir="RTL">&middot;&nbsp; داء القلاع (هو عدوى ناجمة عن الخمائر التي تصيب المهبل، الفم أو الثنيات الجلدية)، يمكنك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه لوصف العلاج المناسب لهذه الحالة</p><p dir="RTL">&middot;&nbsp; اضطرابات الكلى</p><p dir="RTL">&middot;&nbsp; نوبات تشنجية (اختلاجات)، وتُشاهد في المرضى الذين يتناولون جرعات عالية أو يعانون من اضطرابات الكلى</p><p dir="RTL">&middot;&nbsp; دوخة</p><p dir="RTL">&middot;&nbsp; فرط النشاط</p><p dir="RTL">&middot;&nbsp; ظهور بلورات في البول، والتي قد تظهر على هيئة بول متعكر، أو صعوبة التبول أو شعور بعدم الراحة أثناء التبول. احرص دائماً على شرب كميات وفيرة من السوائل للتقليل من فرصة حدوث مثل هذه الأعراض</p><p dir="RTL">&middot;&nbsp; قد يتغير لون اللسان إلى&nbsp; لون الأصفر، البني أو الأسود وقد يبدو وكأنه مشعراً</p><p dir="RTL">&middot;&nbsp; تكسر خلايا الدم الحمراء بشكل مفرط مما يؤدي إلى تلفها وحدوث ما يعرف بفقر الدم. تتضمن علامات ذلك على: تعب، صداع، ضيق التنفس، دوخة، شحوب لون الجلد واصفرار الجلد وبياض العينين</p><p dir="RTL">&middot;&nbsp; انخفاض تعداد خلايا الدم البيضاء</p><p dir="RTL">&middot;&nbsp; انخفاض تعداد الخلايا المسؤولة عن تخثر الدم</p><p dir="RTL">&middot;&nbsp; قد يستغرق النزف وقتاً أطول من المعتاد ليتوقف (يتخثر). قد تلاحظ ذلك إذا أصبت بنزف عبر الأنف أو جرحت نفسك.</p><p dir="RTL">&middot;&nbsp; التهاب الغشاء الواقي المحيط بالدماغ (التهاب السحايا العقيم).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه، في حال حدوث أياً من التأثيرات الجانبية بما في ذلك أية تأثيرات جانبية يحتمل حدوثها ولم يتم ذكرها في هذه النشرة. كما يمكنك الإبلاغ عن التأثيرات الجانبية مباشرة عن طريق:</p><p dir="RTL"><strong>المملكة العربية السعودية:</strong></p><p dir="RTL"><strong>المركز الوطني للتيقظ الدوائي:</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp; مركز الاتصال الموحد: </strong>19999</p><p dir="RTL"><strong>-&nbsp;&nbsp; البريد الإلكتروني: </strong>npc.drug@sfda.gov.sa</p><p dir="RTL"><strong>-&nbsp;&nbsp; الموقع الإلكتروني: </strong>https://ade.sfda.gov.sa/</p><p dir="RTL"><strong>دول الخليج العربي الأخرى:</strong></p><p dir="RTL">- الرجاء الاتصال بجهات الوطنية في كل دولة.</p><p dir="RTL">إن تسجيل التأثيرات الجانبية يساعد في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">-&nbsp; يجب عدم تناول هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة والشريط. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من الشهر المذكور.</p><p dir="RTL">-&nbsp; يحفظ في درجة حرارة أقل من 30&deg;م، في مكان جاف وبعيداً عن الضوء.</p><p dir="RTL">-&nbsp; يجب عدم تناول هذا الدواء<strong> </strong>إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">-&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي أموكسيسيلين. تحتوي كل كبسولة على أموكسيسيلين ثلاثي الهيدرات بما يعادل&nbsp; 500 ملغم من أموكسيسيلين.</p><p dir="RTL">المواد الأخرى: ستيرات المغنيسيوم وجيلاتين.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تتوفر كبسولات<strong> جوڤاموكس&nbsp; </strong>500 ملغم في عبوات تحتوي كلاً منها على 12، 20 أو 100 كبسولة وعبوة خاصة بالمستشفيات تحتوي على 1000 كبسولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
15/7/2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Juvamox 500mg Capsules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each capsule contains:
Item No. 	Material Name 	Scale (mg/ Capsule)
		
	Active Ingredient: 	
1.		Amoxicillin 	500.00
	Use: Amoxicillin Trihydrate *	602.66
		
	Inactive Ingredients: 	
1.		Magnesium stearate 	12.00
2.		Empty Hard Gelatin Capsule Shell, size "0"	1 no. 

Note:
* The fill weight of each capsule is adjusted to fill amoxicillin trihydrate equivalent to amoxicillin 500mg plus overage 5% of Amoxicillin content to ensure potency throughout the shelf life.

For a full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hard-Gelatin Capsules
Description: Hard gelatin capsules size “0” containing granular creamy white powder with characteristic penicillin odour.
Colour: Cap: Green-opaque, printed “Julphar” radical, in black
Body: White opaque, printed “500” radical, in black

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Juvamox </strong>is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1):</p><p>&sect; Acute bacterial sinusitis</p><p>&sect; Acute otitis media</p><p>&sect; Acute streptococcal tonsillitis and pharyngitis</p><p>&sect; Acute exacerbations of chronic bronchitis</p><p>&sect; Community acquired pneumonia</p><p>&sect; Acute cystitis</p><p>&sect; Asymptomatic bacteriuria in pregnancy</p><p>&sect; Acute pyelonephritis</p><p>&sect; Typhoid and paratyphoid fever</p><p>&sect; Dental abscess with spreading cellulitis</p><p>&sect; Prosthetic joint infections</p><p>&sect; <em>Helicobacter pylori</em>&nbsp;eradication</p><p>&sect; Lyme disease</p><p><strong>Juvamox</strong> is also indicated for the prophylaxis of endocarditis.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Posology</u></strong></p><p>The dose of <strong>Juvamox</strong> that is selected to treat an individual infection should take into account:</p><p>&sect; The expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4)</p><p>&sect; The severity and the site of the infection</p><p>&sect; The age, weight and renal function of the patient; as shown below</p><p>The duration of therapy should be determined by the type of infection and the response of the patient, and should generally be as short as possible. Some infections require longer periods of treatment (see section 4.4 regarding prolonged therapy).</p><p><strong><u>Adults and children &ge;40 kg</u></strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:572px"><tbody><tr><td style="vertical-align:top"><p><strong>Indication*</strong></p></td><td style="vertical-align:top"><p><strong>Dose*</strong></p></td></tr><tr><td style="vertical-align:top"><p>Acute bacterial sinusitis</p></td><td rowspan="5" style="vertical-align:top"><p>250 mg to 500 mg every 8 hours or 750 mg to 1 g every 12 hours</p><p>For severe infections 750 mg to 1 g every 8 hours</p><p>Acute cystitis may be treated with 3 g twice daily for one day</p></td></tr><tr><td style="vertical-align:top"><p>Asymptomatic bacteriuria in pregnancy</p></td></tr><tr><td style="vertical-align:top"><p>Acute pyelonephritis</p></td></tr><tr><td style="vertical-align:top"><p>Dental abscess with spreading cellulitis</p></td></tr><tr><td style="vertical-align:top"><p>Acute cystitis</p></td></tr><tr><td style="vertical-align:top"><p>Acute otitis media</p></td><td rowspan="3" style="vertical-align:top"><p>500 mg every 8 hours, 750 mg to 1 g every 12 hours</p><p>For severe infections 750 mg to 1 g every 8 hours for 10 days</p></td></tr><tr><td style="vertical-align:top"><p>Acute streptococcal tonsillitis and pharyngitis</p></td></tr><tr><td style="vertical-align:top"><p>Acute exacerbations of chronic bronchitis</p></td></tr><tr><td style="vertical-align:top"><p>Community acquired pneumonia</p></td><td style="vertical-align:top"><p>500 mg to 1 g every 8 hours</p></td></tr><tr><td style="vertical-align:top"><p>Typhoid and paratyphoid fever</p></td><td style="vertical-align:top"><p>500 mg to 2 g every 8 hours</p></td></tr><tr><td style="vertical-align:top"><p>Prosthetic joint infections</p></td><td style="vertical-align:top"><p>500 mg to 1 g every 8 hours</p></td></tr><tr><td style="vertical-align:top"><p>Prophylaxis of endocarditis</p></td><td style="vertical-align:top"><p>2 g orally, single dose 30 to 60 minutes before procedure</p></td></tr><tr><td style="vertical-align:top"><p><em>Helicobacter pylori</em>&nbsp;eradication</p></td><td style="vertical-align:top"><p>750 mg to 1 g twice daily in combination with a proton pump inhibitor (e.g. omeprazole, lansoprazole) and another antibiotic (e.g. clarithromycin, metronidazole) for 7 days</p></td></tr><tr><td style="vertical-align:top"><p>Lyme disease (see section 4.4)</p></td><td style="vertical-align:top"><p>Early stage: 500 mg to 1 g every 8 hours up to a maximum of 4 g/day in divided doses for 14 days (10 to 21 days)</p><p>Late stage (systemic involvement): 500 mg to 2 g every 8 hours up to a maximum of 6 g/day in divided doses for 10 to 30 days</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><sup>*</sup>Consideration should be given to the official treatment guidelines for each indication</p></td></tr></tbody></table><p><strong><u>Children &lt;40 kg</u></strong></p><p>Children may be treated with amoxicillin capsules, or suspensions.</p><p>Amoxicillin Paediatric Suspension is recommended for children under six months of age.</p><p>Children weighing 40 kg or more should be prescribed the adult dosage.</p><p><em>Recommended doses:</em></p><table border="1" cellspacing="0" cellpadding="0" style="width:572px"><tbody><tr><td style="vertical-align:top"><p><strong>Indication<sup>+</sup></strong></p></td><td style="vertical-align:top"><p><strong>Dose<sup>+</sup></strong></p></td></tr><tr><td style="vertical-align:top"><p>Acute bacterial sinusitis</p></td><td rowspan="6" style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>20 to 90 mg/kg/day in divided doses*</p></td></tr><tr><td style="vertical-align:top"><p>Acute otitis media</p></td></tr><tr><td style="vertical-align:top"><p>Community acquired pneumonia</p></td></tr><tr><td style="vertical-align:top"><p>Acute cystitis</p></td></tr><tr><td style="vertical-align:top"><p>Acute pyelonephritis</p></td></tr><tr><td style="vertical-align:top"><p>Dental abscess with spreading cellulitis</p></td></tr><tr><td style="vertical-align:top"><p>Acute streptococcal tonsillitis and pharyngitis</p></td><td style="vertical-align:top"><p>40 to 90 mg/kg/day in divided doses*</p></td></tr><tr><td style="vertical-align:top"><p>Typhoid and paratyphoid fever</p></td><td style="vertical-align:top"><p>100 mg/kg/day in three divided doses</p></td></tr><tr><td style="vertical-align:top"><p>Prophylaxis of endocarditis</p></td><td style="vertical-align:top"><p>50 mg/kg orally, single dose 30 to 60 minutes before procedure</p></td></tr><tr><td style="vertical-align:top"><p>Lyme disease (see section 4.4)</p></td><td style="vertical-align:top"><p>Early stage: 25 to 50 mg/kg/day in three divided doses for 10 to 21 days</p><p>Late stage (systemic involvement): 100 mg/kg/day in three divided doses for 10 to 30 days</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>+ Consideration should be given to the official treatment guidelines for each indication.</p><p>*Twice daily dosing regimens should only be considered when the dose is in the upper range.</p></td></tr></tbody></table><p><strong><u>Elderly</u></strong></p><p>No dose adjustment is considered necessary.</p><p><strong><u>Renal impairment</u></strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:572px"><tbody><tr><td style="vertical-align:top"><p><strong>GFR (ml/min)</strong></p></td><td style="vertical-align:top"><p><strong>Adults and children &ge; 40 kg</strong></p></td><td style="vertical-align:top"><p><strong>Children &lt; 40 kg<sup>#</sup></strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>greater than 30</strong></p></td><td style="vertical-align:top"><p>no adjustment necessary</p></td><td style="vertical-align:top"><p>no adjustment necessary</p></td></tr><tr><td style="vertical-align:top"><p><strong>10 to 30</strong></p></td><td style="vertical-align:top"><p>maximum 500 mg twice daily</p></td><td style="vertical-align:top"><p>15 mg/kg given twice daily</p><p>(maximum 500 mg twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>less than 10</strong></p></td><td style="vertical-align:top"><p>maximum 500 mg/day.</p></td><td style="vertical-align:top"><p>15 mg/kg given as a single daily dose (maximum 500 mg)</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><sup>#</sup>&nbsp;In the majority of cases, parenteral therapy is preferred.</p></td></tr></tbody></table><p><em>In patients receiving haemodialysis</em></p><p>Amoxicillin may be removed from the circulation by haemodialysis.</p><table border="1" cellspacing="0" cellpadding="0" style="width:572px"><tbody><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p><strong>Haemodialysis</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Adults and children &ge; 40 kg</strong></p></td><td style="vertical-align:top"><p>15 mg/kg/day given as a single daily dose.</p><p>Prior to haemodialysis one additional dose of 15 mg/kg should be administered. In order to restore circulating drug levels, another dose of 15 mg/kg should be administered after haemodialysis.</p></td></tr></tbody></table><p><em>In patients receiving peritoneal dialysis</em></p><p>Amoxicillin maximum 500 mg/day.</p><p><strong><u>Hepatic impairment</u></strong></p><p>Dose with caution and monitor hepatic function at regular intervals (see sections 4.4 and 4.8).</p><p><strong><u>Method of administration</u></strong></p><p><strong>Juvamox </strong>is for oral use.</p><p>Absorption of amoxicillin is unimpaired by food.</p><p>Therapy can be started parenterally according to the dosing recommendations of the intravenous formulation and continued with an oral preparation.</p><p>Swallow with water without opening capsule.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Hypersensitivity to the active substance, to any of the penicillins or to any of the excipients listed in section 6.1.
	History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Hypersensitivity reactions</u></strong></p><p>Before initiating therapy with amoxicillin, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other beta-lactam agents (see sections 4.3 and 4.8).</p><p>Serious and occasionally fatal hypersensitivity (anaphylactoid) reactions have been reported in patients on penicillin therapy. These reactions are more likely to occur in persons with a history of penicillin hypersensitivity to beta-lactam antibiotics and in atopic individuals. If an allergic reaction occurs, amoxicillin therapy must be discontinued and appropriate alternative therapy instituted.</p><p><strong><u>Non-susceptible microorganisms</u></strong></p><p>Amoxicillin is not suitable for the treatment of some types of infection unless the pathogen is already documented and known to be susceptible or there is a very high likelihood that the pathogen would be suitable for treatment with amoxicillin (see section 5.1). This particularly applies when considering the treatment of patients with urinary tract infections and severe infections of the ear, nose and throat.</p><p><strong><u>Convulsions</u></strong></p><p>Convulsions may occur in patients with impaired renal function or in those receiving high doses or in patients with predisposing factors (e.g. history of seizures, treated epilepsy or meningeal disorders (see section 4.8).</p><p><strong><u>Renal impairment</u></strong></p><p>In patients with renal impairment, the dose should be adjusted according to the degree of renal impairment (see section 4.2).</p><p><strong><u>Skin reactions</u></strong></p><p>The occurrence at the treatment initiation of a feverish generalised erythema associated with</p><p>pustula may be a symptom of acute generalised exanthemous pustulosis (AGEP, see section 4.8). This reaction requires amoxicillin discontinuation and contra-indicates any subsequent administration.</p><p>Amoxicillin should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform (erythematous) rash has been associated with this condition following the use of amoxicillin.</p><p><strong><u>Jarisch-Herxheimer reaction</u></strong></p><p>The Jarisch-Herxheimer reaction has been seen following amoxicillin treatment of Lyme disease (see section 4.8). It results directly from the bactericidal activity of amoxicillin on the causative bacteria of Lyme disease, the spirochaete <em>Borrelia burgdorferi</em>. Patients should be reassured that this is a common and usually self-limiting consequence of antibiotic treatment of Lyme disease.</p><p><strong><u>Overgrowth of non-susceptible microorganisms</u></strong></p><p>Prolonged use may occasionally result in overgrowth of non-susceptible organisms.</p><p>Antibiotic-associated colitis has been reported with nearly all antibacterial agents and may range in severity from mild to life threatening (see section 4.8). Therefore, it is important to consider the diagnosis in patients who present with diarrhoea during, or subsequent to, the administration of any antibiotics. Should antibiotic-associated colitis occur, amoxicillin should immediately be discontinued, a physician consulted and appropriate therapy initiated. Anti-peristaltic medicinal products are contra-indicated in this situation.</p><p><strong><u>Prolonged therapy</u></strong></p><p>Periodic assessment of organ system functions; including renal, hepatic and haematopoietic function is advisable during prolonged therapy. Elevated liver enzymes and changes in blood counts have been reported (see section 4.8).</p><p><strong><u>Anticoagulants</u></strong></p><p>Prolongation of prothrombin time has been reported rarely in patients receiving amoxicillin.</p><p>Appropriate monitoring should be undertaken when anticoagulants are prescribed concomitantly. Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation (see sections 4.5 and 4.8).</p><p><strong><u>Crystalluria</u></strong></p><p>In patients with reduced urine output, crystalluria has been observed very rarely, predominantly with parenteral therapy. During the administration of high doses of amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in order to reduce the possibility of amoxicillin crystalluria. In patients with bladder catheters, a regular check of patency should be maintained (see section 4.8 and 4.9).</p><p><strong><u>Interference with diagnostic tests</u></strong></p><p>Elevated serum and urinary levels of amoxicillin are likely to affect certain laboratory tests.</p><p>Due to the high urinary concentrations of amoxicillin, false positive readings are common with chemical methods.</p><p>It is recommended that when testing for the presence of glucose in urine during amoxicillin treatment, enzymatic glucose oxidase methods should be used.</p><p>The presence of amoxicillin may distort assay results for oestriol in pregnant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Probenecid</u></strong></p><p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use of probenecid may result in increased and prolonged blood levels of amoxicillin.</p><p><strong><u>Allopurinol</u></strong></p><p>Concurrent administration of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions.</p><p><strong><u>Tetracyclines</u></strong></p><p>Tetracyclines and other bacteriostatic drugs may interfere with the bactericidal effects of amoxicillin.</p><p><strong><u>Oral anticoagulants</u></strong></p><p>Oral anticoagulants and penicillin antibiotics have been widely used in practice without reports of interaction. However, in the literature there are cases of increased international normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin. If co-administration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of amoxicillin. Moreover, adjustments in the dose of oral anticoagulants may be necessary (see sections 4.4 and 4.8).</p><p><strong><u>Methotrexate</u></strong></p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.</p><p><strong><u>Oral typhoid vaccine</u></strong></p><p>The oral typhoid vaccine is inactivated by antibacterials.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><p>Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. Limited data on the use of amoxicillin during pregnancy in humans do not indicate an increased risk of congenital malformations. Amoxicillin may be used in pregnancy when the potential benefits outweigh the potential risks associated with treatment.</p><p><strong><u>Breastfeeding</u></strong></p><p>Amoxicillin is excreted into breast milk in small quantities with the possible risk of sensitisation. Consequently, diarrhoea and fungus infection of the mucous membranes are possible in the breast-fed infant, so that breast-feeding might have to be discontinued.</p><p>Amoxicillin should only be used during breast-feeding after benefit/risk assessment by the physician in charge.</p><p><strong><u>Fertility</u></strong></p><p>There are no data on the effects of amoxicillin on fertility in humans. Reproductive studies in animals have shown no effects on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. However, undesirable effects may occur (e.g. allergic reactions, dizziness, convulsions), which may influence the ability to drive and use machines (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse drug reactions (ADRs) are diarrhoea, nausea and skin rash.</p><p>The ADRs derived from clinical studies and post-marketing surveillance with amoxicillin, presented by MedDRA System Organ Class are listed below.</p><p>The following terminologies have been used to classify the occurrence of undesirable effects.</p><p>&sect; Very common (&ge;1/10)</p><p>&sect; Common (&ge;1/100 to &lt;1/10)</p><p>&sect; Uncommon (&ge;1/1,000 to &lt;1/100)</p><p>&sect; Rare (&ge;1/10,000 to &lt;1/1,000)</p><p>&sect; Very rare (&lt;1/10,000)</p><p>&sect; Not known (cannot be estimated from the available data)</p><table border="1" cellspacing="0" cellpadding="0" style="width:572px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Infections and infestations</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Mucocutaneous candidiasis</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Blood and lymphatic system disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Reversible leucopenia (including severe neutropenia or agranulocytosis), reversible thrombocytopenia and haemolytic anaemia.</p><p>Prolongation of bleeding time and prothrombin time (see section 4.4).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Immune system disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Severe allergic reactions, including angioneurotic oedema, anaphylaxis, serum sickness and hypersensitivity vasculitis (see section 4.4).</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Jarisch-Herxheimer reaction (see section 4.4).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Nervous system disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hyperkinesia, dizziness and convulsions (see section 4.4).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Gastrointestinal disorders</u></strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><em>Clinical Trial Data</em></p></td></tr><tr><td style="vertical-align:top"><p>*Common</p></td><td style="vertical-align:top"><p>Diarrhoea and nausea</p></td></tr><tr><td style="vertical-align:top"><p>*Uncommon</p></td><td style="vertical-align:top"><p>Vomiting</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><em>Post-marketing Data</em></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Antibiotic associated colitis (including pseudomembraneous colitis and haemorrhagic colitis see section 4.4).</p><p>Black hairy tongue</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Hepatobiliary disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Hepatitis and cholestatic jaundice. Moderate rise in AST and/or ALT.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Skin and subcutaneous tissue disorders</u></strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><em>Clinical Trial Data</em></p></td></tr><tr><td style="vertical-align:top"><p>*Common</p></td><td style="vertical-align:top"><p>Skin rash</p></td></tr><tr><td style="vertical-align:top"><p>*Uncommon</p></td><td style="vertical-align:top"><p>Urticaria and pruritus</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><em>Post-marketing Data</em></p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>Skin reactions such as erythema multiforme and Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous and exfoliative dermatitis and acute generalised exanthematous pustulosis (AGEP) (see section 4.4).</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Renal and urinary tract disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Interstitial nephritis</p><p>Crystalluria (see sections 4.4 and 4.9 Overdose)</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>* The incidence of these AEs was derived from clinical studies involving a total of approximately 6,000 adult and paediatric patients taking amoxicillin.</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p><strong><u>To report any side effect(s):</u></strong></p><p>&sect; <strong>Saudi Arabia:</strong></p><p>The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Centre: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p><p>&sect; <strong>Other GCC States: </strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Symptoms and signs of overdose</u></strong></p><p>Gastrointestinal symptoms (such as nausea, vomiting and diarrhoea) and disturbance of the fluid and electrolyte balances may be evident. Amoxicillin crystalluria, in some cases leading to renal failure, has been observed. Convulsions may occur in patients with impaired renal function or in those receiving high doses (see sections 4.4 and 4.8).</p><p><strong><u>Treatment of intoxication</u></strong></p><p>Gastrointestinal symptoms may be treated symptomatically, with attention to the water/electrolyte balance.</p><p>Amoxicillin may be removed from the circulation by haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> penicillins with extended spectrum; ATC code: J01CA04.</p><p><strong><u>Mechanism of action</u></strong></p><p>Amoxicillin is a semisynthetic, broad-spectrum, beta-lactam penicillin antibiotic that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bacterial peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.</p><p>Amoxicillin is susceptible to degradation by beta-lactamases produced by resistant bacteria and therefore the spectrum of activity of amoxicillin alone does not include organisms which produce these enzymes.</p><p><strong><u>Pharmacokinetic/pharmacodynamic relationship</u></strong></p><p>The time above the minimum inhibitory concentration (T&gt;MIC) is consider to be the major determinant of efficacy for amoxicillin.</p><p><strong><u>Mechanisms of resistance</u></strong></p><p>The main mechanisms of resistance to amoxicillin are:</p><p>&sect; Inactivation by bacterial beta-lactamases.</p><p>&sect; Alteration of PBPs, which reduce the affinity of the antibacterial agent for the target.</p><p>Impermeability of bacteria or efflux pump mechanisms may cause or contribute to bacterial resistance, particularly in Gram-negative bacteria.</p><p><strong><u>Breakpoints</u></strong></p><p>MIC breakpoints for amoxicillin are those of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) version 5.0.</p><table border="1" cellspacing="0" cellpadding="0" style="width:572px"><tbody><tr><td style="vertical-align:top"><p><strong>Organism</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>MIC breakpoint (mg/L)</strong></p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p><strong>Susceptible &le;</strong></p></td><td style="vertical-align:top"><p><strong>Resistant &gt;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Enterobacteriaceae</p></td><td style="vertical-align:top"><p>8<sup>1</sup></p></td><td style="vertical-align:top"><p>8</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus</em>&nbsp;spp.</p></td><td style="vertical-align:top"><p>Note<sup>2</sup></p></td><td style="vertical-align:top"><p>Note<sup>&nbsp;2</sup></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterococcus</em>&nbsp;spp.<sup>3</sup></p></td><td style="vertical-align:top"><p>4</p></td><td style="vertical-align:top"><p>8</p></td></tr><tr><td style="vertical-align:top"><p>Streptococcus groups A, B, C and G</p></td><td style="vertical-align:top"><p>Note<sup>&nbsp;4</sup></p></td><td style="vertical-align:top"><p>Note<sup>&nbsp;4</sup></p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em></p></td><td style="vertical-align:top"><p>Note<sup>&nbsp;5</sup></p></td><td style="vertical-align:top"><p>Note<sup>&nbsp;5</sup></p></td></tr><tr><td style="vertical-align:top"><p>Viridans group streptococci</p></td><td style="vertical-align:top"><p>0.5</p></td><td style="vertical-align:top"><p>2</p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em></p></td><td style="vertical-align:top"><p>2<sup>6</sup></p></td><td style="vertical-align:top"><p>2<sup>6</sup></p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em></p></td><td style="vertical-align:top"><p>Note<sup>&nbsp;7</sup></p></td><td style="vertical-align:top"><p>Note<sup>&nbsp;7</sup></p></td></tr><tr><td style="vertical-align:top"><p><em>Neisseria meningitidis</em></p></td><td style="vertical-align:top"><p>0.125</p></td><td style="vertical-align:top"><p>1</p></td></tr><tr><td style="vertical-align:top"><p>Gram positive anaerobes except<em>Clostridium difficile</em><sup>8</sup></p></td><td style="vertical-align:top"><p>4</p></td><td style="vertical-align:top"><p>8</p></td></tr><tr><td style="vertical-align:top"><p>Gram negative anaerobes<sup>8</sup></p></td><td style="vertical-align:top"><p>0.5</p></td><td style="vertical-align:top"><p>2</p></td></tr><tr><td style="vertical-align:top"><p><em>Helicobacter pylori</em></p></td><td style="vertical-align:top"><p>0.125<sup>9</sup></p></td><td style="vertical-align:top"><p>0.125<sup>9</sup></p></td></tr><tr><td style="vertical-align:top"><p><em>Pasteurella multocida</em></p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>1</p></td></tr><tr><td style="vertical-align:top"><p>Non- species related breakpoints<sup>10</sup></p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>8</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><sup>1</sup>Wild type Enterobacteriaceae are categorised as susceptible to aminopenicillins. Some countries prefer to categorise wild type isolates of&nbsp;<em>E. coli</em>&nbsp;and&nbsp;<em>P. mirabilis</em>&nbsp;as intermediate. When this is the case, use the MIC breakpoint S &le; 0.5 mg/L</p><p><sup>2</sup>Most staphylococci are penicillinase producers, which are resistant to amoxicillin. Methicillin resistant isolates are, with few exceptions, resistant to all beta-lactam agents.</p><p><sup>3</sup>Susceptibility to amoxicillin can be inferred from ampicillin</p><p><sup>4</sup>The susceptibility of streptococcus groups A, B, C and G to penicillins is inferred from the benzylpenicillin susceptibility.</p><p><sup>5</sup>Breakpoints relate only to non-meningitis isolates. For isolates categorised as intermediate to ampicillin avoid oral treatment with amoxicillin. Susceptibility inferred from the MIC of ampicillin.</p><p><sup>6</sup>Breakpoints are based on intravenous administration. Beta-lactamase positive isolates should be reported resistant.</p><p><sup>7</sup>Beta lactamase producers should be reported resistant</p><p><sup>8</sup>Susceptibility to amoxicillin can be inferred from benzylpenicillin.</p><p><sup>9</sup>The breakpoints are based on epidemiological cut-off values (ECOFFs), which distinguish wild-type isolates from those with reduced susceptibility.</p><p><sup>10</sup>The non-species related breakpoints are based on doses of at least 0.5 g x 3or 4 doses daily (1.5 to 2 g/day).</p></td></tr></tbody></table><p>The prevalence of resistance may vary geographically and with time for selected species, and local information resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0" style="width:572px"><tbody><tr><td style="vertical-align:top"><p><strong><em>In vitro</em></strong><strong>&nbsp;susceptibility of micro-organisms to Amoxicillin</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Commonly Susceptible Species</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p><p><em>Enterococcus faecalis</em></p><p>Beta-hemolytic streptococci (Groups A, B, C and G)</p><p><em>Listeria monocytogenes</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Species for which acquired resistance may be a problem</u></strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Escherichia coli</em></p><p><em>Haemophilus influenzae</em></p><p><em>Helicobacter pylori</em></p><p><em>Proteus mirabilis</em></p><p><em>Salmonella</em>&nbsp;typhi</p><p><em>Salmonella</em>&nbsp;paratyphi</p><p><em>Pasteurella multocida</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p><p>Coagulase negative staphylococcus</p><p><em>Staphylococcus aureus</em><sup>&pound;</sup></p><p><em>Streptococcus pneumoniae</em></p><p>Viridans group streptococcus</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive anaerobes:</u></p><p><em>Clostridium&nbsp;</em>spp.</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative anaerobes:</u></p><p><em>Fusobacterium</em>&nbsp;spp.</p></td></tr><tr><td style="vertical-align:top"><p><u>Other:</u></p><p><em>Borrelia burgdorferi</em></p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Inherently resistant organisms</u></strong><sup>&dagger;</sup></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p><p><em>Enterococcus faecium</em>&dagger;</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Acinetobacter</em>&nbsp;spp.</p><p><em>Enterobacter</em>&nbsp;spp.</p><p><em>Klebsiella</em>&nbsp;spp.</p><p><em>Pseudomonas</em>&nbsp;spp.</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative anaerobes:</u></p><p><em>Bacteroides</em>&nbsp;spp. (many strains of&nbsp;<em>Bacteroides fragilis</em>&nbsp;are resistant).</p></td></tr><tr><td style="vertical-align:top"><p><u>Others:</u></p><p><em>Chlamydia</em>&nbsp;spp.</p><p><em>Mycoplasma</em>&nbsp;spp.</p><p><em>Legionella</em>&nbsp;spp.</p></td></tr><tr><td style="vertical-align:top"><p><sup>&dagger;</sup>&nbsp;Natural intermediate susceptibility in the absence of acquired mechanism of resistance.</p><p><sup>&pound;</sup>&nbsp;Almost all&nbsp;<em>S.aureus</em>&nbsp;are resistant to amoxicillin due to production of penicillinase. In addition, all methicillin-resistant strains are resistant to amoxicillin.</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Absorption</u></strong></p><p>Amoxicillin fully dissociates in aqueous solution at physiological pH. It is rapidly and well absorbed by the oral route of administration. Following oral administration, amoxicillin is approximately 70% bioavailable. The time to peak plasma concentration (T<sub>max</sub>) is approximately one hour.</p><p>The pharmacokinetic results for a study, in which an amoxicillin dose of 250 mg three times daily was administered in the fasting state to groups of healthy volunteers are presented below.</p><table border="1" cellspacing="0" cellpadding="0" style="width:572px"><tbody><tr><td style="vertical-align:top"><p>C<sub>max</sub></p></td><td style="vertical-align:top"><p>T<sub>max</sub>&nbsp;*</p></td><td style="vertical-align:top"><p>AUC&nbsp;<sub>(0-24h)</sub></p></td><td style="vertical-align:top"><p>T &frac12;</p></td></tr><tr><td style="vertical-align:top"><p>(&mu;g/ml)</p></td><td style="vertical-align:top"><p>(h)</p></td><td style="vertical-align:top"><p>((&mu;g.h/ml)</p></td><td style="vertical-align:top"><p>(h)</p></td></tr><tr><td style="vertical-align:top"><p>3.3 &plusmn; 1.12</p></td><td style="vertical-align:top"><p>1.5 (1.0-2.0)</p></td><td style="vertical-align:top"><p>26.7 &plusmn; 4.56</p></td><td style="vertical-align:top"><p>1.36 &plusmn; 0.56</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p>*Median (range)</p></td></tr></tbody></table><p>In the range of 250 to 3000 mg the bioavailability is linear in proportion to dose (measured as C<sub>max</sub>&nbsp;and AUC). The absorption is not influenced by simultaneous food intake.</p><p>Haemodialysis can be used for elimination of amoxicillin.</p><p><strong><u>Distribution</u></strong></p><p>About 18% of total plasma amoxicillin is bound to protein and the apparent volume of distribution is around 0.3 to 0.4 l/kg.</p><p>Following intravenous administration, amoxicillin has been found in gall bladder, abdominal tissue, skin, fat, muscle tissues, synovial and peritoneal fluids, bile and pus. Amoxicillin does not adequately distribute into the cerebrospinal fluid.</p><p>From animal studies there is no evidence for significant tissue retention of drug-derived material. Amoxicillin, like most penicillins, can be detected in breast milk (see section 4.6).</p><p>Amoxicillin has been shown to cross the placental barrier (see section 4.6).</p><p><strong><u>Biotransformation</u></strong></p><p>Amoxicillin is partly excreted in the urine as the inactive penicilloic acid in quantities equivalent to up to 10 to 25% of the initial dose.</p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>Elimination</u></strong></p><p>The major route of elimination for amoxicillin is via the kidney.</p><p>Amoxicillin has a mean elimination half-life of approximately one hour and a mean total clearance of approximately 25 l/hour in healthy subjects. Approximately 60 to 70% of the amoxicillin is excreted unchanged in urine during the first 6 hours after administration of a single 250 mg or 500 mg dose of amoxicillin. Various studies have found the urinary excretion to be 50-85% for amoxicillin over a 24 hour period.</p><p>Concomitant use of probenecid delays amoxicillin excretion (see section 4.5).</p><p><strong><u>Age</u></strong></p><p>The elimination half-life of amoxicillin is similar for children aged around 3 months to 2 years and older children and adults. For very young children (including preterm newborns) in the first week of life the interval of administration should not exceed twice daily administration due to immaturity of the renal pathway of elimination. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p><p><strong><u>Gender</u></strong></p><p>Following oral administration of amoxicillin/ to healthy males and female subjects, gender has no significant impact on the pharmacokinetics of amoxicillin.</p><p><strong><u>Renal impairment</u></strong></p><p>The total serum clearance of amoxicillin decreases proportionately with decreasing renal function (see sections 4.2 and 4.4).</p><p><strong><u>Hepatic impairment</u></strong></p><p>Hepatically impaired patients should be dosed with caution and hepatic function monitored at regular intervals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on studies of safety pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction and development.</p><p>Carcinogenicity studies have not been conducted with amoxicillin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:567px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive Ingredients: </u></strong></p></td></tr><tr><td style="vertical-align:top"><p>1.&nbsp;&nbsp;&nbsp;&nbsp; Magnesium stearate</p></td></tr><tr><td style="vertical-align:top"><p>2.&nbsp;&nbsp;&nbsp;&nbsp; Empty Hard Gelatin Capsule Shell, size &quot;0&quot;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months from the date of manufacturing 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C, in a dry place, protected from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect;&nbsp; <strong>Pack of 12 Capsules:</strong> 1 x 12&rsquo;s Capsules in an Aluminium foil PVC-PVDC coated blister, packed in a printed carton along with a leaflet.</p><p>&sect;&nbsp; <strong>Pack of 20 Capsules:</strong> 2 x 10&rsquo;s Capsules in an Aluminium foil PVC-PVDC coated blister, packed in a printed carton along with a leaflet.</p><p>&sect;&nbsp; <strong>Pack of 100 Capsules:</strong> 10 x 10&rsquo;s Capsules in an Aluminium foil PVC-PVDC coated blister, packed in a printed carton along with a leaflet.</p><p>&sect;&nbsp; <strong>Pack of 1000 Capsules:</strong> 100 x 10&rsquo;s Capsules in an Aluminium foil PVC-PVDC coated blister, packed in a printed carton along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.:   (9717) 2 461 461
Fax No.:   (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                15. July. 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>